BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37582919)

  • 21. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
    Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
    Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database.
    Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C
    Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
    Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
    JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis.
    Ke Q; Wang L; Lin Z; Liu H; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Liu J; Zeng Y
    BMC Cancer; 2023 Sep; 23(1):850. PubMed ID: 37697239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis.
    Ma KW; Chok KSH; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM
    Hepatol Int; 2018 Mar; 12(2):167-173. PubMed ID: 29450868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
    Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
    JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor location influences perioperative and oncologic outcomes in solitary intrahepatic cholangiocarcinoma following curative resection: a multi-center analysis.
    Li H; Liu R; Li J; Li J; Wu H; Wang G; Li D
    HPB (Oxford); 2022 Sep; 24(9):1543-1550. PubMed ID: 35393220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
    Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
    Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
    Si A; Li J; Yang Z; Xia Y; Yang T; Lei Z; Cheng Z; Pawlik TM; Lau WY; Shen F
    Ann Surg Oncol; 2019 Jun; 26(6):1841-1850. PubMed ID: 30843164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and survival outcomes after hepatectomy in patients with non-alcoholic fatty liver and hepatitis B-related hepatocellular carcinoma.
    Jung YB; Yoo JE; Han DH; Kim KS; Choi JS; Kim DY; Park YN; Choi GH
    HPB (Oxford); 2021 Jul; 23(7):1113-1122. PubMed ID: 33309568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Jeong S; Tong Y; Sha M; Gu J; Xia Q
    Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.
    Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O
    Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma using the MEGNA score: A multi-institutional analysis.
    Shaikh CF; Alaimo L; Moazzam Z; Endo Y; Lima HA; Dawood Z; Munir MM; Pawlik TM
    J Surg Oncol; 2023 Jan; 127(1):73-80. PubMed ID: 36106350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Ann Transplant; 2017 Jan; 22():42-52. PubMed ID: 28123170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.